Article
Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.
The Journal of investigative dermatology - 1 Feb 1998
Darling T N, Yee C, Koh B, McGrath J A, Bauer J W, Uitto J, Hintner H, Yancey K B
Abstract excerpt
Patients with generalized atrophic benign epidermolysis bullosa often show decreased expression of type XVII collagen, a transmembrane hemidesmosomal protein encoded by COL17A1. This report documents a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa, and applies a new methodology to define and characterize the resulting mRNA splice variants. Mutational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
